Coagulation Analyzer Market / Hemostasis Analyzers Market Size by Product (Clinical Laboratory, consumables, reagents, PoCT, Manual, Automated), Test (PT,Fibrinogen,APTT, ACT, D Dimer), Technology (Optical, Mechanical), End User (Clinical Labs, Hospitals) & Region - Global Forecast to 2025
Market Growth Outlook Summary
The global coagulation analyzer market growth forecasted to transform from USD 3.8 billion in 2020 to USD 5.0 billion by 2025, driven by a CAGR of 5.7%. Emerging economies such as India, China, and Brazil are expected to provide a wide range of opportunities for players in the industry. Furthermore, the increasing prevalence of cardiovascular diseases and blood disorders and the rising geriatric population are expected to boost the growth of this market in the coming years.
Prothrombin time tests accounted for the largest market share in 2019
In 2019, the prothrombin time testing segment accounted for the largest share of the coagulation analyzers market. Growth in this market segment can be attributed to the high usage of prothrombin time tests in measuring the time it takes for blood to clot. These tests are used to monitor patients implanted with mechanical heart valves, ventricular assist devices, chronic atrial fibrillation, venous embolism and thrombosis of deep vessels of lower extremities, deep venous thrombosis, and pulmonary embolism.
Clinical laboratories segment dominated the coagulation analyzers market in 2019
On the basis of end user, the coagulation analyzers market is segmented into clinical laboratories, hospitals, and other end users. In 2019, the clinical laboratories segment accounted for the largest share of the coagulation analyzers market. This can be attributed to the large volume of coagulation testing being performed at these facilities.
Asia Pacific market to grow at the highest rate from 2020 to 2025
The coagulation analyzers market in the Asia Pacific is expected to grow at a high CAGR in the coming years. The factors contributing to the high growth of this market include the rising incidence/prevalence of blood-related disorders, increasing government initiatives for the improvement of healthcare infrastructure, rising number of general surgeries, and growth in research activities in several Asia Pacific countries. Moreover, the rapidly growing geriatric population (and the subsequent increase in the incidence of thalassemia, sickle-cell anemia, and leukemia) and healthcare infrastructure improvements in countries such as Japan, China, and Australia are expected to support the growth of this market in the coming years.
The major players operating in the coagulation analyzers market are Abbott Laboratories (US), Danaher (US), Siemens Healthineers Group (Germany), Sysmex Group (US), Thermo Fisher Scientific (US), Horiba (Japan), Nihon Kohden (Japan), Roche Diagnostics (Switzerland), Maccura Biotechnology Co. Ltd. (China), Bio Group Medical System (Italy), Genrui Biotech Inc. (China), A&T Corporation (Japan), Beijing Succeeder Technology Inc. (China), Diagnostica Stago SAS (France), Helena Laboratories (US), Hycel (Austria), Eurolyser (Austria), Bpc Biosed Srl (Italy), Robimes India Pvt. Ltd (India), Meril Life Sciences (India), ERBA Diagnostics, Inc. (US), Sclavo Diagnostics International S.r.l (Italy), Haematonics (US), Biosystems S.A. (Spain), and ACON (US).
Scope of the Coagulation Analyzer Industry
Report Metric |
Details |
Market Revenue Size in 2020 |
$3.8 billion |
Projected Revenue Size by 2025 |
$5.0 billion |
Industry Growth Rate |
Poised to Grow at a CAGR of 5.7% |
Market Driver |
Increasing prevalence of cardiovascular diseases and blood disorders |
Market Opportunity |
Emerging markets |
This research report categorizes the coagulation analyzer market to forecast revenue and analyze trends in each of the following submarkets:
By Product
-
Clinical Laboratory Analyzers
-
Consumables
- Reagents
- Standards, Controls, and Calibrations
-
Systems
- Automated Systems
- Manual Systems
- Semi-automated Systems
-
Consumables
- Point-of-care Testing Analyzers
By Test
- Prothrombin Time Testing
- Fibrinogen Testing
- Activated Clotting Time Testing
- Activated Partial Thromboplastin Time Testing
- D-dimer Testing
- Platelet Function Tests
- Anti-Factor XA Tests
- Heparin & Protamine Dose-response Tests for ACT
- Other Coagulation Tests
By Technology
- Optical
- Mechanical
- Electrochemical
- Other Technologies
- Coagulation Analyzers Market, by End User
- Clinical Laboratories
- Hospitals
- Other End Users
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- Japan
- China
- India
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Recent Developments:
- In 2019, Nihon Kohden established a hematology analyzer reagent factory in Dubai.
- In 2018, Sysmex launched the Automated Blood Coagulation Analyzers CN-6000 and CN-3000
- In 2017, Roche Diagnostics launched the cobast 711 coagulation analyzer
Key Questions Addressed in the Report:
- What are the growth opportunities in the coagulation analyzers market across major regions in the coming years?
- Emerging countries have immense opportunities for the growth and adoption of coagulation analyzers. Will this scenario continue during the next five years?
- What are the various coagulation analyzers and their respective market shares in the overall market?
- What are the new trends and advancements in the coagulation analyzers market?
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
The study involved four major activities for estimating the current size of the coagulation analyzers market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources, such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the coagulation analyzers market. Other MnM proprietary reports were also referred to estimate the market size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the market have been identified through extensive secondary research
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size - using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the coagulation analyzers industry.
Report Objectives
- To define, describe, and forecast the coagulation analyzers market on the basis of test, product, technology, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall coagulation analyzers market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the global coagulation analyzers market with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the coagulation analyzers market and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as partnerships, agreements, and collaborations; acquisitions; expansions; and product launches & approvals in the coagulation analyzers market
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Company Information
- Further split for LATAM and MEA countries
Product Analysis
-
Product Matrix, which gives a detailed comparison of the product portfolios of top companies
Growth opportunities and latent adjacency in Coagulation Analyzer Market